Literature DB >> 16207253

Release of host-derived membrane vesicles following pilus-mediated adhesion of Neisseria gonorrhoeae.

Darcy B Gill1, Dirk Spitzer, Michael Koomey, John E Heuser, John P Atkinson.   

Abstract

Following attachment of Neisseria gonorrhoeae to human epithelial cell lines, the cellular pilus receptor CD46 is shed from the cell and accumulates in the media. In this report, we assess Neisseria-induced alterations in CD46 surface distribution and characterize this complement regulatory protein following its release from the infected cell. Within 3 h of attachment of gonococci to human epithelial cell lines, CD46 is enriched beneath sites of microcolony adhesion. By 6 h post infection, differential ultracentrifugation of culture media from ME-180 monolayers resulted in sedimentation of structurally and functionally intact CD46. Electron microscopy of these 100,000 g pellets revealed 30-200 nm vesicles. These vesicles likely originated from the host cell as they contained additional host cell surface proteins including CD55 and the epidermal growth factor receptor. Further, these vesicles were visualized by quick-freeze, deep-etch electron microscopy in association with the surface of infected ME-180 cells and with pili of adherent gonococci. Like CD46 shedding, CD46 redistribution and vesicle release were insensitive to colchicine and cytochalasin-D but dependent on expression of the pilus retraction protein PilT. This vesiculation may represent a host cell defence response in which surface proteins that are commonly exploited by pathogens, such as CD46, are removed from the cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207253     DOI: 10.1111/j.1462-5822.2005.00584.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  8 in total

Review 1.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 2.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

3.  Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection.

Authors:  Nathan J Weyand; Christine M Calton; Dustin L Higashi; Kristen J Kanack; Magdalene So
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

4.  CD46 Contributes to the severity of group A streptococcal infection.

Authors:  Lena Lövkvist; Hong Sjölinder; Rahma Wehelie; Helena Aro; Anna Norrby-Teglund; Laura Plant; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

5.  Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion.

Authors:  Michael P Sanderson; Sascha Keller; Angel Alonso; Svenja Riedle; Peter J Dempsey; Peter Altevogt
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

6.  Monoclonal antibody detection of CD46 clustering beneath Neisseria gonorrhoeae microcolonies.

Authors:  Nathan J Weyand; Shaun W Lee; Dustin L Higashi; Daniel Cawley; Paul Yoshihara; Magdalene So
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

7.  Adhesion to nanofibers drives cell membrane remodeling through one-dimensional wetting.

Authors:  Arthur Charles-Orszag; Feng-Ching Tsai; Daria Bonazzi; Valeria Manriquez; Martin Sachse; Adeline Mallet; Audrey Salles; Keira Melican; Ralitza Staneva; Aurélie Bertin; Corinne Millien; Sylvie Goussard; Pierre Lafaye; Spencer Shorte; Matthieu Piel; Jacomine Krijnse-Locker; Françoise Brochard-Wyart; Patricia Bassereau; Guillaume Duménil
Journal:  Nat Commun       Date:  2018-10-25       Impact factor: 14.919

8.  Neisseria meningitidis differentially controls host cell motility through PilC1 and PilC2 components of type IV Pili.

Authors:  Philippe C Morand; Marek Drab; Krishnaraj Rajalingam; Xavier Nassif; Thomas F Meyer
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.